The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...
A Nashville infusion therapy company has quietly opened a flurry of D.C.-area locations within the past few months — and intends to bring more to the market this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback